Feasibility and Effectiveness Study of Implementing Prism Adaptation as a Treatment for Spatial Neglect After Stroke

Sponsor
Nova Scotia Health Authority (Other)
Overall Status
Completed
CT.gov ID
NCT02680171
Collaborator
(none)
10
1
2
42.7
0.2

Study Details

Study Description

Brief Summary

Spatial neglect is a common attention disorder after right hemisphere stroke and is associated with decreased independence and quality of life. Despite its high prevalence in the stroke population, there is currently no standard of care for the treatment of neglect. Prism adaptation (PA) is a promising rehabilitation technique, however incorporation into clinical care has been limited likely due to the lack of standardized procedures. The investigators have developed a computerized PA technique designed to better engage patients and assist clinicians. In this study the investigators aim to evaluate the feasibility and effectiveness of the computerized PA procedure in a typical health care setting, with the hypothesis that the PA procedure will improve patient's neglect symptoms.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Prism Goggles
  • Other: Non-Shifting Goggles
N/A

Detailed Description

There is an unmet need for effective and feasible interventions for spatial neglect after right hemisphere stroke. Neglect is a frequent problem after stroke and makes it difficult for individuals to pay attention and notice information coming from the left side of their world. Thus, they often miss food on the left side of their plate, fail to wash or groom the left side of their face or body, or run into objects on the left side of the hall when walking or using their wheelchair. Neglect is associated with slower recovery, reduced independence, longer stays in rehabilitation and need for more resources when discharged. The investigators have developed a novel and simple computerized prism adaptation (PA) procedure for treating neglect, but the investigators don't know yet whether it is feasible and effective in a typical health care setting. Thus, the purpose of this project is to conduct a randomized, controlled clinical trial, comparing the PA method to a control intervention for the treatment of neglect. The investigators will measure feasibility of use in a clinical setting and effectiveness in terms of impairment (i.e., does PA improve neglect symptoms?), activities (i.e., does having PA improve independence in daily activities) and health care outcomes (i.e., does giving PA shorten length of stay and decrease the need for resources on discharge?). By treating neglect with PA, the overall aim is to improve the health care outcomes for those with neglect and to reduce need for extended hospital care.

A controlled, randomized design will be used in the present study. Patients will be randomly assigned (with stratification related to neglect severity) to PA (experimental) or sham (control) conditions and complete 10, 30-minute intervention sessions over approximately two weeks. These intervention sessions will involve a novel and simple computerized prism adaptation, Peg-The-Mole (PTM). Outcome measures will be collected before and after each treatment, as well as at baseline, and a three month follow-up over the phone.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trialRandomized controlled trial
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Feasibility and Effectiveness Study of Implementing Prism Adaptation as a Treatment for Spatial Neglect After Right Hemisphere Stroke
Actual Study Start Date :
Feb 6, 2018
Actual Primary Completion Date :
Aug 30, 2021
Actual Study Completion Date :
Aug 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prism adaptation treatment

Prism Goggles with ten-degree rightward deviating prism lenses will be used to implement prism adaptation treatment, in addition to standard care.

Behavioral: Prism Goggles
Patients in the experimental condition will wear prism goggles while completing a computerized aiming task. This prisms will shift the patients' vision 10 degrees rightward, causing a recalibration of visuo-motor information. Prism adaptation will be carried out over several days.

Sham Comparator: Sham prism adaptation treatment

Non-Shifting Goggles (sham) will be worn by patients in the control condition. These goggles do not shift the patients visual field.

Other: Non-Shifting Goggles
Non-shifting goggles are worn instead of prism goggles, while completing the same computerized aiming task as those assigned to the prism adaptation.
Other Names:
  • Control condition
  • Outcome Measures

    Primary Outcome Measures

    1. Change in Sunnybrook Neglect Assessment Procedure (SNAP) [Taken at baseline and after the intervention has been completed (approximately two weeks post-treatment start)]

      Test of neglect severity

    Secondary Outcome Measures

    1. Change in Johnny Shirt Visual Scanning Task [Taken at baseline, after five intervention sessions are completed (approximately 1 week post-treatment start), and after the intervention (approximately two weeks post-treatment start)]

      Test of neglect severity

    2. Change in Behavioural Inattention Test - Behaviour subtests (BIT-B) [Taken at baseline and after the intervention (approximately two weeks post-treatment start)]

      Test of neglect severity

    3. Change in Catherine Bergego Scale (CBS) [Taken at baseline and after the intervention (approximately two weeks post-treatment start)]

      Scale of neglect impact on daily activities

    4. Change in Halifax Neglect Severity Scale [Taken after the intervention (approximately two weeks post-treatment start) and at follow-up (approximately 3 months post-discharge from the Nova Scotia Rehabilitation and Arthritis Centre)]

      Scale of neglect impact on daily activities

    5. Change in Functional Independence Measure (FIM) [Taken at baseline and at discharge up to 3 months]

      Measure of functional independence

    6. Frenchay Activities Index [Taken at approximately 3 months post-discharge]

      Measure of functional independence

    7. Length of inpatient stay at the Rehabilitation Centre [From admission to discharge up to 3 months]

      Measure of hospital utilization

    8. Discharge destination from Rehabilitation Centre [At time of discharge up to 3 months from admission]

      Measure of hospital utilization

    9. Change in Proprioceptive and Visuo-motor pointing midline tasks [Taken from immediately before and at end of treatment session, about 10 minutes]

      Used to assess prism adaptation after-effects

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Experience mild to severe symptoms of neglect (as measured by the Sunnybrook Neglect Assessment Procedure and/or as determined based on clinical judgment of the treating team)

    • Be willing to participate

    • Be able to consent to participate

    • Be medically stable

    • Have normal or corrected to normal vision

    • Be able to point to targets presented on a computer screen.

    Exclusion Criteria:
    • Other neurological disease (e.g., Multiple Sclerosis, Parkinsons disease)

    • Dementia

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Nova Scotia Health Authority Halifax Nova Scotia Canada B3H3N5

    Sponsors and Collaborators

    • Nova Scotia Health Authority

    Investigators

    • Principal Investigator: Gail A Eskes, PhD, Nova Scotia Health Authority; Dalhousie University
    • Principal Investigator: Richard Braha, PhD, Nova Scotia Health Authority
    • Study Chair: Anne Sophie Champod, PhD, Dalhousie University; Acadia University
    • Study Chair: Joy Boyce, BScOT, Nova Scotia Health Authority
    • Study Chair: Myrna King, BScOT, Nova Scotia Health Authority

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Gail Eskes, Dr., Nova Scotia Health Authority
    ClinicalTrials.gov Identifier:
    NCT02680171
    Other Study ID Numbers:
    • TRICSpatialNeglect2016
    First Posted:
    Feb 11, 2016
    Last Update Posted:
    Dec 17, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Gail Eskes, Dr., Nova Scotia Health Authority
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 17, 2021